Orca Capital AG 13D/13G Filings for Phio Pharmaceuticals Corp. (PHIO)

Orca Capital AG 13D and 13G filings for Phio Pharmaceuticals Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-23
3:45 pm
Purchase
2024-12-1913GPhio Pharmaceuticals Corp.
PHIO
Orca Capital AG514,965
9.900%
514,965increase
(New Position)
Filing